Loading...
OTCM
MRPI
Market cap55kUSD
Dec 08, Last price  
0.00USD
Name

Mera Pharmaceuticals Inc

Chart & Performance

D1W1MN
OTCM:MRPI chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
0k
-100.00%
10,0001,0770100,00001,032,64448,570776,109909,613387,972386,757470,379609,984599,091288,888302,6240
Net income
0k
P
-1,297,932-1,863,203-2,748,275-4,100,000-4,626,235-4,091,571-541,890-1,830,885-1,104,551-1,305,704-508,407-322,266-1,945,356-192,878-537,838-187,6800
CFO
0k
P
-469,528-1,983,448-1,367,227-3,200,000-3,342,524-3,036,788-377,151-1,087,733-1,249,081-567,493-202,674-44,326-118,591-26,4518,555-71,8370

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Mera Pharmaceuticals, Inc. focuses on the development and commercialization of natural products from microalgae using its proprietary and large-scale photobioreactor technology. The company is also involved in the development of sea salt; and operation of family entertainment center focused on promoting health and wellness through the Villari’s system of martial arts. In addition, it provides food production and delivery services. Mera Pharmaceuticals, Inc. was founded in 1983 and is based in Las Vegas, Nevada.
IPO date
Jun 13, 2002
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FY
2020‑10
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT